Literature DB >> 28087204

Assessment of Nurse Perspectives on an Emergency Department-Based Routine Opt-Out HIV Screening Program.

Sara Heinert, Julius Carter, Cammeo Mauntel-Medici, Janet Lin.   

Abstract

Routine opt-out HIV screening is recommended for everyone between 13 and 64 years of age. An urban, academic emergency department implemented a nurse-driven routine opt-out HIV screening program. The aim of our study was to assess program uptake and opportunities to improve the program from the perspectives of emergency nurses. Emergency nurses completed a brief prediscussion questionnaire and then participated in a focus group or semi-structured one-on-one interview to elicit feedback on the routine opt-out HIV screening program. All 16 participants felt adequately prepared for the screening program. Several themes emerged from the discussions, including challenges of specific patient characteristics and overall nurse and patient support for the program. One thread across themes was the importance of good language and communication skills in such programs. While there are opportunities to improve nurse-driven routine opt-out HIV testing programs in emergency settings, this program was found to be accepted by emergency nurses.
Copyright © 2016 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV screening; emergency department; emergency nurse

Mesh:

Year:  2016        PMID: 28087204     DOI: 10.1016/j.jana.2016.12.004

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  1 in total

1.  Brief Report: "Give Me Some Time": Facilitators of and Barriers to Uptake of Home-Based HIV Testing During Household Contact Investigation for Tuberculosis in Kampala, Uganda.

Authors:  Mari Armstrong-Hough; Joseph Ggita; Irene Ayakaka; David Dowdy; Adithya Cattamanchi; Jessica E Haberer; Achilles Katamba; J Lucian Davis
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.